Stratec (ETR:SBS) Trading Down 0.9% – Here’s What Happened

Stratec SE (ETR:SBS)’s stock price dropped 0.9% during mid-day trading on Monday . The stock traded as low as €17.78 and last traded at €17.80. Approximately 8,129 shares changed hands during mid-day trading, an increase of 30% from the average daily volume of 6,253 shares. The stock had previously closed at €17.96.

Stratec Trading Down 0.9%

The company has a current ratio of 4.33, a quick ratio of 1.65 and a debt-to-equity ratio of 49.40. The company has a fifty day simple moving average of €17.63 and a 200-day simple moving average of €19.97. The company has a market capitalization of $213.84 million, a PE ratio of 21.36, a PEG ratio of 10.43 and a beta of 0.80.

Stratec Company Profile

Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018.